Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

SHE:300878 Revenue

Zhejiang Wecome Pharmaceutical Company had revenue of 36.75M CNY in the quarter ending September 30, 2025, a decrease of -50.25%. This brings the company's revenue in the last twelve months to 131.67M, down -71.28% year-over-year. In the year 2024, Zhejiang Wecome Pharmaceutical Company had annual revenue of 351.20M, down -32.41%.

• Revenue (ttm): 131.67M
• Revenue Growth: -71.28%
• P/S Ratio: 34.66
• Revenue / Employee: 202.56K
• Employees: 650
• Market Cap: 4.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	351.20M	-168.42M	-32.41%
Dec 31, 2023	519.62M	-12.82M	-2.41%
Jan 1, 2023	532.44M	-100.51M	-15.88%
Jan 1, 2022	632.95M	10.19M	1.64%
Dec 31, 2020	622.77M	-19.03M	-2.97%